| Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness J Shafrin, K Bognar, K Everson, M Brauer, DN Lakdawalla, FM Forma ClinicoEconomics and outcomes research, 573-585, 2018 | 14 | 2018 |
| Incremental health care burden of treatment-resistant depression among Commercial, Medicaid, and Medicare payers A Shrestha, M Roach, K Joshi, JJ Sheehan, P Goutam, K Everson, ... Psychiatric Services 71 (6), 593-601, 2020 | 12 | 2020 |
| Healthcare resource use and expenditures in patients newly diagnosed with paroxysmal supraventricular tachycardia NC Sacks, PL Cyr, MT Preib, K Everson, DR Wood, S Raza, SD Pokorney The American Journal of Cardiology 125 (2), 215-221, 2020 | 10 | 2020 |
| Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated … J Shafrin, A Marijam, AV Joshi, FS Mitrani-Gold, K Everson, R Tuly, ... Antimicrobial Resistance & Infection Control 11 (1), 133, 2022 | 9 | 2022 |
| The diagnostic trajectory of infants and children with clinical features of genetic disease BE Schroeder, N Gonzaludo, K Everson, KS Than, J Sullivan, RJ Taft, ... NPJ Genomic Medicine 6 (1), 98, 2021 | 8 | 2021 |
| Physical activity and bleeding outcomes among people with severe hemophilia on extended half‐life or conventional recombinant factors A Shrestha, J Su, N Li, C Barnowski, N Jain, K Everson, AB Jena, K Batt Research and Practice in Thrombosis and Haemostasis 5 (1), 94-103, 2021 | 8 | 2021 |
| Disparities in the management of newly diagnosed paroxysmal supraventricular tachycardia for women versus men in the United States NC Sacks, K Everson, MR Emden, PL Cyr, DR Wood, S Raza, KA Wood, ... Journal of the American Heart Association 9 (19), e015910, 2020 | 8 | 2020 |
| Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database J Shafrin, A Marijam, AV Joshi, FS Mitrani-Gold, K Everson, R Tuly, ... Antimicrobial Resistance & Infection Control 11 (1), 84, 2022 | 5 | 2022 |
| Quantifying the economic burden of myelodysplastic syndromes among elderly US patients J Shafrin, S Green, R Murphy, K Everson, S Dennen, K Price, K Batt Blood 134, 2151, 2019 | 3 | 2019 |
| 194. Progression of an Uncomplicated Urinary Tract Infection Among Female Patients with Susceptible and Non-Susceptible Urine Isolates: Findings from an Integrated Delivery Network J Shafrin, A Marijam, AV Joshi, FS Mitrani-Gold, K Everson, R Tuly, ... Open Forum Infectious Diseases 8 (Supplement_1), S118-S118, 2021 | 1 | 2021 |
| Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C--Lowering Therapies. JP MacEwan, LM Zhao, K Everson, L Liu, D Lautsch, F Sun, ... American Journal of Managed Care 27 (4), 2021 | 1 | 2021 |
| CAR-T therapy displays favorable gains in health outcomes and competitive cost-effectiveness when compared with past innovative cancer treatments J Baumgardner, K Everson, M Brauer, J Zhang, Y Hao, J Liu, ... Blood 132, 322, 2018 | 1 | 2018 |
| Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets AA Habib, N Sacks, C Cool, S Durgapal, S Dennen, K Everson, T Hughes, ... Neurology 102 (2), e207863, 2024 | | 2024 |
| Genetic test utilization in a large US healthcare database of patients with indications of rare genetic disease B Schroeder, N Gonzaludo, K Everson, J Sullivan, RJ Taft, J Belmont EUROPEAN JOURNAL OF HUMAN GENETICS 28 (SUPPL 1), 685-685, 2020 | | 2020 |
| PCV22 Trends in Diagnostic Testing Utilization and Expenditures in Patients with NEWLY Diagnosed Paroxysmal Supraventricular Tachycardia in the United States DS Chew, N Sacks, PL Cyr, KA Everson, DR Wood, SD Pokorney Value in Health 23, S490, 2020 | | 2020 |
| Patient Factors Associated With Delayed Diagnosis of Paroxysmal Supraventricular Tachycardia and the Resultant Impact on Healthcare Resource Utilization N Sacks, M Preib, K Everson, P Cyr, D Wood, S Pokorney Circulation 140 (Suppl_1), A16222-A16222, 2019 | | 2019 |
| Healthcare Resource Use and Expenditures in Patients Newly Diagnosed with Paroxysmal Supraventricular Tachycardia in the United States NC Sacks, K Everson, PL Cyr, MT Preib, DR Wood, SD Pokorney PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 8-9, 2019 | | 2019 |
| CV3 VARIATIONS IN HEALTHCARE RESOURCE USE AND EXPENDITURES BY AGE IN PATIENTS UNDER AGE 65 NEWLY DIAGNOSED WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) IN THE UNITED STATES NC Sacks, KA Everson, PL Cyr, M Emden, M Preib, DR Wood, ... Value in Health 22, S38, 2019 | | 2019 |
| CR2 US NATIONAL PAYERS ANALYSIS OF THE INCREMENTAL HEALTHCARE BURDEN AMONG PATIENTS WITH TREATMENT-RESISTANT DEPRESSION A Shrestha, P Goutam, M Roach, K Everson, S Sison, K Joshi, ... Value in Health 22, S37, 2019 | | 2019 |
| Healthcare Resource Use and Expenditures in Younger Women and Men Newly Diagnosed with Paroxysmal Supraventricular Tachycardia (PSVT) NC Sacks, K Everson, PL Cyr, DR Wood, SD Pokorney Circulation: Cardiovascular Quality and Outcomes 12 (Suppl_1), A274-A274, 2019 | | 2019 |
